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Abstract
We have developed an integrated database for Mycobacterium tuberculosis H37Rv (Mtb)
that collates information on protein sequences, domain assignments, functional annota-
tion and 3D structural information along with protein–protein and protein–small
molecule interactions. SInCRe (Structural Interactome Computational Resource) is de-
veloped out of CamBan (Cambridge and Bangalore) collaboration. The motivation for de-
velopment of this database is to provide an integrated platform to allow easily access
and interpretation of data and results obtained by all the groups in CamBan in the field of
Mtb informatics. In-house algorithms and databases developed independently by vari-
ous academic groups in CamBan are used to generate Mtb-specific datasets and are inte-
grated in this database to provide a structural dimension to studies on tuberculosis. The
SInCRe database readily provides information on identification of functional domains,
genome-scale modelling of structures of Mtb proteins and characterization of the small-
molecule binding sites within Mtb. The resource also provides structure-based function
annotation, information on small-molecule binders including FDA (Food and Drug
Administration)-approved drugs, protein–protein interactions (PPIs) and natural com-
pounds that bind to pathogen proteins potentially and result in weakening or elimination
of host–pathogen protein–protein interactions. Together they provide prerequisites for
identification of off-target binding.
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Introduction
Mycobacterium tuberculosis H37Rv (Mtb), a causative
agent of tuberculosis (TB), has remained a major health
concern globally. Based on the World Health Organization
(WHO) latest reports, it is estimated that there have been
8.6 million new cases of TB reported in 2012 and a total of
1.3 million TB deaths (1). Most patients are treated for TB
using first-line drugs, rifampicin and isoniazid. Together
with the other first-line drugs, ethambutol and pyrazina-
mide, these two drugs form the basic ingredients of com-
bination chemotherapy followed by the WHO directly
observed treatment short course strategy (2). Second-line
drugs, such as fluoroquinolones, and injectables like kana-
mycin, capreomycin and amikacin, are relied upon when
the first-line drugs fail to control the disease. However in
recent times, many antibiotic-resistant strains of Mtb have
been reported. Multi-drug resistant TB is an Mtb strain re-
sistant to rifampicin and isoniazid. Furthermore, acquisi-
tion of resistance towards fluoroquinolone, along with at
least one of the injectable drugs, causes extensively drug re-
sistant TB (3). The emergence of resistant strains to the
first- and second-line drugs currently used poses a mam-
moth challenge for control of TB and cure of the infected.
Off-target effects, which are often discovered at the later
stages of drug discovery research, have led to failure of
many new medicines. Thus, there is an urgent need to dis-
cover ways of identifying off-target sites for drugs at an early
stage in research. Detailed structural knowledge of the inter-
actions between molecules in the cell provides one way of
approaching this problem. The objective would be to define
the structural interactome, an inventory of the various inter-
actions between macromolecules and both natural and syn-
thetic small molecules. The structural interactome can
augment molecular-level interaction networks and provide a
rich source of information on interactions between biolo-
gical molecules and natural or synthetic ligands. Information
on interactions between host and pathogen proteins will be
helpful in identifying targets among pathogen proteins.
Integrated databases defining the structural interac-
tome, bringing together information on protein sequences
and structures, binding site properties, small molecules and
their interactions, provide a valuable resource. Existing
integrated databases on TB, TB Database (4, 5) and
Tuberculist (6), provide information on genome, prote-
ome, expression as well as corresponding references in the
scientific literature but provide no information on struc-
tural interactomics comprising of binding sites, small mol-
ecules, druggability analysis of targets and functional
domain assignments. This work from the CamBan
(Cambridge—Bangalore) collaboration, involving four in-
dependent research groups from Cambridge and
Bangalore, brings together various resources developed by
these research groups and elsewhere to provide an ex-
tended Mtb structural-interactome resource. Each group
has contributed towards the data specific to TB using in-
house algorithms and databases developed and established
individually over the years. The algorithms used to gener-
ate the data are designed to address and enrich sequence
and structural data along with various small-molecule
interactions. The database also incorporates systems-based
analysis and provides list of high-confidence targets.
Sensitive profile-based techniques such as hmmscan of
HMMER3.0 (7), Reverse PSI-BLAST (Reverse Position-
Specific Iterative Basic Local Alignment Search Tool) (8)
and HHblits (9) were used to achieve enhanced domain an-
notation for the proteins. Structural annotation of M. tuber-
culosis proteome (10) and CHOPIN (11) database provided
structural data for many proteins. PocketDepth (12),
PocketMatch (13) and PocketAlign (14) algorithms are used
for binding site prediction and comparison. Protein domain
analysis of unannotated genes was pursued using a computa-
tionally intensive bioinformatics pipeline called PURE
(Prediction of Unassigned Regions) (15). The dataset from
CREDO (16), a protein–ligand interaction database for drug
discovery, TIMBAL (17), a database of small molecules
disrupting protein–protein interactions and TIBLE (http://
mordred.bioc.cam.ac.uk/tible/), a database of small mol-
ecules against Mtb and ligand-based off-target predictions,
are connected in structural interactome computational re-
source (SInCRe). High-confidence drug targets derived from
targetTB (18) have been included in the database. Drug tar-
gets have also been identified by a sequence-based approach
with the help of FDA-approved drugs and are incorporated
into the database. An interface has also been provided to in-
tegrate the data available from other external resources like
STRING (19), STITCH (20) and Tuberculist (6). Future
works from these groups will be mapped on to Mtb-specific
dataset, and SInCRe will be updated on a regular basis.
Database
The integrated suite of databases was developed to provide
detailed sequence and structure-based dimensionality to aid
in drug-discovery pipelines. The data integrated here were
obtained from the databases and webservers developed indi-
vidually by the four research groups in CamBan. In-house
algorithms and databases are the primary resources for the
database. Figure 1 details the various data types.
Sequence-based analysis
Algorithms and datasets used.
The development of similarity-search procedures with the
use of profiles such as Position Specific Scoring Matrices
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(PSSMs) (8, 21), Environment-Specific Substitution
Tables (22) and Hidden Markov Models (HMMs) (7) has
proven to be sensitive in detecting remote homologues reli-
ably. Combination of such sensitive profile-based tech-
niques resulted in the structural and functional annotations
for 95% of the Mtb proteome. Sensitive approaches such
as hmmscan available through HMMER3.0 package, RPS-
BLAST and HHblits were employed against sequence and
structural profiles of various domain families obtained
from Pfam (23), SUPERFAMILY (24), MulPSSM (25, 26)
and the HH-suite database (ftp://toolkit.genzentrum.lmu.
de/pub/HHsuite/databases/hhsuite_dbs/).
MulPSSM, developed by one of our research groups, is
a searchable database of multiple PSSM profiles. The mul-
tiple profiles for a given domain family correspond to an
alignment, wherein multiple sequences from that family
are used as reference. The current version comprises 403
107 profiles for 14 831 Pfam domain families (Pfam v.27)
and 14 235 profiles corresponding to 3856 structural fami-
lies in PALI (Phylogeny and ALIgnment of homologous
protein structures) (27) database based on SCOP
(Structural Classification Of Proteins) (version 1.75).
Assessment of structure and function predictions.
Each of the associations made was assessed based on
e-value and alignment length. For associations made using
RPS-BLAST against MulPSSM database, an e-value cut-off
of 0.01 was used in addition to a profile-coverage thresh-
old of 70%. For domain assignments made using hmmscan
against the Pfam database, profile-specific gathering
threshold cut-offs were used to extract reliable hits. For
hits identified by HHblits, an e-value threshold of 0.001
was used to associate domain families. In the searches
against SUPERFAMILY HMM database using hmmscan
software, the hits with e-values better than 0.0001 were
considered to be reliable and are included in the database.
Domain assignments for all the proteins were manually
curated to maximize residue (64%) and sequence (89%)
coverage.
Structural/functional domains for un-annotated pro-
teins as well as those with unassigned regions were deter-
mined with help of the computationally intensive pipeline,
PURE (15), developed by one of our groups. Cases where
all the earlier approaches were unsuccessful in recognition
of structural or functional domains, a fold-recognition al-
gorithm PHYRE2 (28) was employed. A confidence cut-off
of 90% was considered to retrieve folds reliably. This exer-
cise was essentially an attempt to assess the foldability of
the protein in question. Also, transfer of function based on
homology was pursued using HHblits against non-redun-
dant sequence database at an e-value cut-off of 0.001 and
query coverage threshold of 60%.
All the hits of the earlier approaches were coupled with
manual intervention to ensure maximum residue and se-
quence coverage of Mtb proteome (29).
Drug target identification based on sequence information.
Repurposing drugs has been regarded as a promising
strategy mainly due to the reduced cost and time involved.
A target identification methodology which essentially
Figure 1. Various data resources contributing to SInCRe.
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integrates homology and pharmacological information
(G. Ramakrishnan, N. Chandra and N. Srinivasan, in
preparation) facilitated recognition of 132 FDA-approved
drugs which could be repurposed for 56 potential targets
in Mtb. This methodology comprises three steps: explor-
ation of evolutionary relationship between targets of
known FDA-approved drugs and Mtb proteins, structural
elucidation of binding sites of Mtb proteins homologous
to known targets and evaluation of predicted binding sites
with the help of protein–ligand docking. Evolutionary
relationships were explored with the help of a sensitive
profile-based iterative search tool, jackhmmer(30), at an
e-value threshold of 0.0001. An initial filtering step to
eliminate drugs known to act on human proteins ensured
that the ‘anti-targets’ in host are not picked up. The reli-
ably identified relationships picked were further probed
for the conservation of ligand-binding site residues across
known targets and the Mtb proteins homologous to these
targets. Structural information was taken from Protein
Data Bank (PDB) (31) for Mtb and high-confidence struc-
tural models obtained from ModBase (32) for proteins
with no known structure were used to assess the binding
pockets. A structural alignment algorithm, TM-align
(33), was effective in identification of highly similar local
structural matches (TM-score> 0.50) between targets
and their corresponding homologues in Mtb. Finally, the
shortlisted proteins in Mtb predicted to serve as potential
targets were evaluated using FDA-approved drugs with
the help of an efficient protein–ligand docking tool, Glide
(34–36) (http://www.schrodinger.com/Glide). A total of
132 FDA-approved drugs (Supplementary Table S1) were
thus identified, which could be repurposed for 56 poten-
tial target proteins in Mtb.
Structure-based analysis
Structural proteome of Mtb.
Structural annotation of the M. tuberculosis proteome
was carried out by one of the groups (10). PDB holds a
total of 324 crystal structures of Mtb proteins and com-
parative models were generated for 2737 proteins, thus
giving structure availability for 70% of the Mtb prote-
ome. Structural models were generated using Modpipe, a
software suite along with ModBase (32), a database of
models generated using comparative modelling. The struc-
tural models need to be of high confidence and reliability
as they play a central role to all the further analysis carried
out. To assess the reliability of the protein structural mod-
els, various structure verification methods including statis-
tical scoring potential (37, 38), secondary structure
compatibility (39) and stereochemical quality check (40)
were used. In the case of multi-domain proteins 3D
models of individual domains are presented. Only those
binding sites that were detected within the domains are
analysed.
The CHOPIN (11) database (http://structure.bioc.cam.
ac.uk/chopin) assigns structural domains and generates
homology models for 2911 sequences, corresponding to
73% of the proteome. Conformational states, character-
istic of different oligomeric states and ligand binding, re-
flect various functional states of the proteins. Additionally,
CHOPIN includes structural analyses of mutations poten-
tially associated with drug resistance. The model number,
sequence coverage and zscore are displayed on the SInCRe
result page with links provided to CHOPIN webpage
(http://mordred.bioc.cam.ac.uk/chopin/about) that pro-
vides model details and an option to download the models.
Detection of binding sites.
Computational methods for binding site detection can be
classified into three broad categories based on their
approaches: (i) evolutionary methods based on structure–
sequence alignment (ii) energy-based methods using chem-
ical probes and (iii) geometric approaches that scan the 3D
structure of the protein to detect pockets. Each of these
methods has its own strengths and limitations with respect
to different aspects such as accuracy in detection and pre-
diction, computational time, complexity and features cap-
tured. All the three methods were used in this study to
minimize the prediction error and increase the confidence.
The methods used are, a grid-based geometric method,
PocketDepth (12), evolutionary method, Ligsite (41) and
energy-based method, SiteHound. PocketDepth is an in-
house method that uses depth-based clustering algorithm
for detecting putative binding sites in the given protein
structures. The idea that depth is defined by the centrality
of empty subspaces in a protein structure is used to identify
the pockets from all the protein structures. The
PocketDepth algorithm was later combined with
LIGSITEcsc, which uses Connolly’s surface (42) to identify
surface–solvent–surface events that involves grooves and
then detects binding sites in a given protein by mapping the
degree of conservation of the residues in the selected sur-
face. All the pockets detected by PocketDepth that are
within 5 A˚ radius of the predicted LIGSITEcsc pockets
were selected. SiteHound (43), an energy method that
searches for interaction zones favourable for a methyl
probe within the protein, was used on all the pockets iden-
tified as a filter to fetch out final set of consensus ligand
binding sites.
Other than the binding sites identified by these meth-
ods, pockets were also selected based on the experimen-
tally characterized binding site residues in each protein in
the proteome or in their homologues. This was done by
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fetching entries from the database using respective general
feature format files obtained from UniProt database (44).
Possible binding sites were identified by scanning each pro-
tein sequence in the proteome with known binding motifs
from the Prosite (45) database to make sure they were not
missed out by other methods in the workflow (46). The
binding sites detected can be viewed using Jmol plugin and
also co-ordinates of these binding pockets can be down-
loaded in pdb format.
Drug binding site database and comparison.
DrugBank (47) and DrugPort were used to prepare a com-
bined list of drugs or drug-like compounds; these included
approved and experimental drugs and nutraceuticals.
XML data files were obtained from these two databases
and later parsed to extract information on proteins com-
plexed with any of these drugs present in PDB. The bind-
ing sites were then extracted from these complexes.
Residues of all atoms that lie within 4.5A˚ of any atom in
the drug molecule were extracted as part of the binding
site. Ten thousand six hundred and fifty-eight (from
Drugbank) (Supplementary Table S2)þ 2516 (from
Drugport) (Supplementary Table S3) drug-binding sites
were obtained from PDB through this process. High-
confidence targets from Mtb were scanned using these
known drug-binding sites, and also drug-binding sites
were scanned for similarities against different binding site
clusters.
Structural interactome.
The structural interactomics database CREDO (16) pro-
vides details of pairwise atomic interactions of intermo-
lecular and intramolecular contacts between ligands and
macromolecule for the structures in PDB. The PDB codes
in the database are linked to the results of CREDO. This
database stores interaction between atoms as structural
interaction fingerprints as implemented by Deng et al.
(48). Thirteen different interaction types such as hydrogen
bonds, halogen bonds, carbonyl interactions and
more are currently implemented in CREDO. Polypeptide-
residue mapping is done onto UniProt. This allows identi-
fication of modified, non-standard or mutated proteins in
the PDB compared with sequence in UniProt. Further,
small-molecule and protein interaction details are pro-
vided in the database. Physico-chemical properties are
calculated for all the small molecules in PDB and these
properties are important for evaluating its drug-likeness.
Topological similarities of the small molecules based on
2D and 3D descriptors are also retrieved from the data-
base. With these data, CREDO provides major structural
interaction details to study small-molecule binding
properties. The PDB structures used as templates for
building models in SInCRe are linked to the CREDO
database.
Structure binding molecules.
TIMBAL (17), a database of small molecules disrupting
protein–protein interactions, provides us with a list of
small molecules relevant to the proteins of Mtb. Previously
constructed by manual curation, now TIMBAL is auto-
mated to identify a list of protein–protein interaction
modulators. The PPI targets and their orthologs are identi-
fied by UniProt identifiers. Small molecules related to these
proteins are searched using UniProt identifiers in ChEMBL
database. The homologues of known protein–protein
interactions to the proteins in Mtb are identified and
corresponding small molecules are listed. Totally 21 Mtb
proteins are homologous to proteins in TIMBAL database
corresponding to 11 targets.
Ligand-based off-target prediction and small-molecule
data.
There are two main approaches to predict off-target activ-
ity. The structure-based approach relies on the similarity
of the targets binding pockets, whereas the ligand-based
approach connects targets based on the similarity of their
ligands. The two methodologies complement each other
(49). TIBLE (http://mordred.bioc.cam.ac.uk/tible/) col-
lects small-molecule data (Minimal Inhibitory
Concentration (MIC) for mycobacterium and binding to
isolated Mtb targets) from the ChEMBL database (50)
and the CDD (51). There are 75 Mtb targets with small-
molecule binding data. For each of these targets, three in-
dependent algorithms—SEA (52), PharmMapper (53) and
PASS (54) are used to derive off-target ligand-based pre-
dictions. Link from TIBLE to PharmMapper offers
pharmacophore-matching platform for potential target
identification. The details of small molecules and ligand-
based off-target are integrated into the SInCRe database
and also linked to the TIBLE page for detailed
information.
Systems-based target identification
Identification of high confidence drug targets is a primary
factor for efficient drug treatment. TargetTB (18), a
comprehensive in silico target identification pipeline, was
developed by one of the groups. The pipeline is built by
incorporating network-based analysis of the protein–pro-
tein interactions, a flux-balance analysis of the reactome,
phenotype-essentiality data derived from experiments, tar-
getability assessment based on sequence and structure ana-
lysis using in-house novel algorithms. Initially proteins that
are important for the survival of Mtb were identified using
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flux balance and network analyses. Subsequently compara-
tive genomics with the host was carried out. Finally the
viability of a protein to be a potential drug target was as-
sessed using novel methods for structural analysis of bind-
ing sites. Further, expression-data analysis, providing
correlation and non-similarity measures of target proteins
to gut flora proteins and also to ‘anti-target’ proteins in the
host, was analysed extensively. Four hundred and fifty-one
high-confidence entries were identified by this analysis
pipeline. These short-listed targets have been further ana-
lysed through phylogenetic profiling against 228 pathogen
genomes to identify antibiotic targets of broad spectrum
especially those specific to TB. Target proteins significant
to mycobacterial persistence and drug resistance mechan-
isms have also been analysed and reported. The details of
the targets identified through TargetTB pipeline has been
integrated into this database.
Other resources
External data from STRING (19), a database of known
and predicted protein–protein interactions, STITCH (20),
a database of protein–small molecule interactions and
Tuberculist (6) for primary details about each Mtb protein
are integrated into the SInCRe database.
Coverage of theM. tuberculosis proteome in
the database
Our analysis of the repertoire of M. tuberculosis proteins,
using a multitude of sensitive techniques, has generated a
resource of information including structural and functional
domain assignments, potential drug-targets and small-
molecule binders including FDA-approved drugs. Figure 2
summarizes the percentage coverage achieved for M. tuber-
culosis proteins and indicates that 3495 of 4018 proteins
could be associated with at least one functional domain
(Pfam domain) assignment while 3131 proteins could ei-
ther be associated with structural domains (SCOP do-
mains) or with proteins of known structure. In terms of
domain assignment alone, a total of 3566 proteins (89%)
could be associated with at least one structural or func-
tional domain. Due to the combined use of sensitive
profile-based techniques, the percentage of M. tuberculosis
proteins associated with functional domains is 3% higher
than the annotations available in databases such as Pfam;
and the percentage coverage achieved in terms of structural
domains is 8% higher than the structural annotations
available in databases such as SUPERFAMILY.
Systematic means to identify potential drug targets in
M. tuberculosis has resulted in recognition of 498 high-
confidence targets, constituting 12% of the proteome. The
SInCRe database also includes information on protein–
protein interactions within M. tuberculosis as documented
in resources such as STRING. Approximately 23 000
known or predicted protein–protein interactions in M. tu-
berculosis are mediated by 2386 (59%) proteins.
Our attempt to integrate information from diverse re-
sources provides a unified platform to explore and investi-
gate the usefulness of a predicted target or a small
molecule in the context of drug development and drug dis-
covery for TB.
Database and web interface
The SInCRe database is created by integrating resources
from various other databases for 4018 Mtb proteins. This
database has been developed on the Linux-Apache-
Figure 2. Percentage coverage of M. tuberculosis proteins in the database. Numbers in brackets denote absolute values.
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MySQL-PHP platform. Sequence- and structure-level
datasets have been stored in efficiently designed relational
database schema. The web interface is developed using
BootStrap (http://twitter.github.com/bootstrap). This pro-
vides cascading style sheets framework and javascript func-
tionality. CytoscapeWeb (55), a java plugin, is used for
interactive display of protein–protein and protein–small
molecules interaction networks. Protein structures are rep-
resented in 3D using JSmol, a JavaScript-based molecular
viewer from Jmol, an open-source Java viewer for chemical
structures in 3D (http://www.jmol.org/). The modelled
structures and sequences can be downloaded in PDB and
FASTA formats, respectively. The tables in webpages are
sortable and searchable, giving the user ease of acquiring
data of interest.
The database can be queried using Rv IDs, gene name,
UniProt ID, Pfam ID and Tuberculist functional classifica-
tion. The dataset can be browsed for information available
based on a few methods for limited list of Rv IDs.
Prediction of drug interactions using SInCRe
Protein kinases and phosphatases constitute important
classes of drug targets due to the critical roles played by
them in reversible protein phosphorylation that regulates
many biological processes. There are many studies that re-
port the development of potent inhibitors for these enzymes
involved in protein phosphorylation to treat different types
of cancer and autoimmune diseases (56). Serine/threonine
protein kinases (STPKs) are one such class of kinases that
specifically phosphorylate the hydroxyl group of one or
more serine and threonine residues in the substrate protein.
Mycobacterium tuberculosis (Mtb) genome houses 11 of
such STPK genes and all of these are known to regulate cru-
cial signalling processes, playing an important role in regu-
lating physiology and virulence of the pathogen (57).
Of the 11 STPKs in Mtb, nine (PknA, PknB, PknD,
PknE, PknF, PknH, PknI, PknJ and PknL) are receptors
containing a transmembrane helix with extracellular sen-
sory domain and intracellular kinase domain, thus acting
as signal transducers. The other two kinases (PknG and
PknK) are cytoplasmic containing a regulatory domain and
could hence play a role in intracellular responses. Here, we
explore the role of one such STPK – PknD (Rv0931c), as a
putative drug target through the information present in
SInCRe database. PknD acts a receptor kinase with extra-
cellular sensory domain adopting a six-bladed b propeller
structure (PDB ID: 1RWL, 1RWI) (58), and an intracellu-
lar kinase domain. The 3D structure of intracellular kinase
domain could be derived using homology modelling using
the crystal structure of PknE (PDB ID: 2H34) kinase do-
main as the template which share 59.7% sequence identity
with the target. Although the substrate and the ligand for
the PknD is yet to be discovered, the gene neighbourhood
analysis reveals that it could play an essential role in phos-
phate transport. This is complemented by the fact that the
growth of DpknD strain is compromised in a phosphate
deficient medium (59). Recently, PknD has been observed
to phosphorylate the N-terminal domain of Rv0516c, a pu-
tative regulator of sigma factor SigF (60). These three
genes—PknD, Rv0516c and SigF play an important role in
osmosensory signalling pathway (61). Moreover, a screen
for identifying important genes for central nervous system
infection by Mtb also identified PknD to be essential as
DpknD strain was observed to be defective for invasion of
central nervous system (62).
The binding site prediction exercise carried out on a
proteome-scale involving a consensus of different types of
algorithm (46) identified a putative binding site present at
the interface of N-terminal and C-terminal lobe of kinase
domain in PknD (Figure 3A). A systematic binding site
comparison of this predicted pocket against a database of
approved drug-binding sites yielded nilotinib (NIL) bind-
ing site from human mitogen activated protein kinase 11
protein (PDB ID: 3GP0) as the topmost hit with binding
site similarity score (PMAX) (13) of 0.703. A binding site
alignment of the predicted pocket with this known NIL
binding site using PocketAlign algorithm (14) reveals the
observed similarity and the differences in the binding sites
(Figure 3B). Although the similarity of these protein kin-
ases with the human counterparts can increase the risk of
toxicity, there are supporting evidences in the literature
that have successfully exploited the ATP-binding sites to
achieve the selectivity. There are FDA-approved drugs that
selectively bind to active and inactive conformations of the
protein kinases to achieve the selectivity (56). The differ-
ences in kinase inhibitor binding sites (depicted as wire-
frame in Figure 3B) could be used as anchor points in
fragment-based drug discovery to achieve the selectivity to-
wards Mtb protein kinases. Interestingly, the binding sites
of many of the anti-retroviral protease inhibitors like nelfi-
navir and lopinavir were also observed to have similarity
to the predicted binding site in PknD. These observations
are supported by the fact that nelfinavir is found to have
anti-cancerous property attributed to its ability to weakly
inhibit multiple protein kinases (63). One such anti-
retroviral protease inhibitor—saquinavir (Ligand code:
ROC), having high binding site similarity with the pre-
dicted binding site in PknD was explored further through
computational docking using AutoDock Vina (Figure 3C)
(64). The computationally predicted binding affinity (8.1
kcal/mol) was found to be comparable to the native sa-
quinavir complexed with HIV-protease (9.4 kcal/mol).
The best pose obtained through computational docking
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predicted the residues—ARG101, GLU142, ARG93 and
GLU31 present in the predicted binding site to have crucial
interaction with the saquinavir. These interesting drug as-
sociations can be readily obtained from the ‘protein–small
molecule associations’ tab presented in the SInCRe data-
base. The SInCRe database can thus, be used to generate
readily testable hypothesis for anti-tubercular drug
discovery.
Conclusion
SInCRe is an integrated suite of databases that provides the
outcome of extensive sequence and structural studies of Mtb
proteins. Sequence-based domain assignment and structural
analysis of binding sites act as a resource to help in the iden-
tification off-target interactions of drug molecules, know-
ledge of which is useful in the design of novel drugs for M.
tuberculosis. Future updates will include incorporation of
other resources from Cambridge and Bangalore.
Supplementary Data
Supplementary data are available at Database Online.
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